Danimer Scientific (NYSE:DNMR) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. This is a 27.78 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $10.224 million which missed the analyst consensus estimate of $11.063 million by 7.59 percent. This is a 14.27 percent decrease over sales of $11.926 million the same period last year.
Danimer Scientific Q1 2024 GAAP EPS $(0.26) Beats $(0.31) Estimate, Sales $10.224M Miss $11.063M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.